share_log

Pharming Group (NASDAQ:PHAR) Hits New 12-Month High at $13.01

Financial News Live ·  Nov 2, 2022 23:11

Pharming Group (NASDAQ:PHAR – Get Rating) reached a new 52-week high during trading on Wednesday . The company traded as high as $13.01 and last traded at $11.09, with a volume of 10 shares changing hands. The stock had previously closed at $11.40.

Wall Street Analyst Weigh In

Separately, TheStreet upgraded Pharming Group from a "d+" rating to a "c" rating in a research report on Monday, August 15th.

Get Pharming Group alerts:

Pharming Group Stock Performance

The company has a market capitalization of $662.59 million, a P/E ratio of 27.81 and a beta of -0.32. The business has a 50-day moving average of $10.84 and a 200-day moving average of $9.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 5.40 and a quick ratio of 4.68.

Pharming Group (NASDAQ:PHAR – Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.01 by $0.03. The company had revenue of $50.15 million during the quarter, compared to the consensus estimate of $51.99 million. Pharming Group had a return on equity of 8.98% and a net margin of 14.90%. On average, sell-side analysts anticipate that Pharming Group will post 0.03 EPS for the current year.

About Pharming Group

(Get Rating)

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema.

Further Reading

  • Get a free copy of the StockNews.com research report on Pharming Group (PHAR)
  • 3 Reasons Snap Stock Could Snap Back
  • Freshpet: A Fresh Time To Buy Into This Growth Story?
  • Nomad Foods: A Defensive Stock on the Move
  • The Market Is Suddenly All Ears on Warner Music Group
  • Uber Stock Surge On The Back Of Profitabilty

Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment